Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricNVONovo Nordisk A/SNVSNovartis AGAZNAstraZeneca PLC
Snapshot
Price$37.35$140.87$157.00
Market cap$210.12B$261.56B$284.73B
Valuation
P/E9.2x19.5x24.1x
Forward P/E7.9x17.9x18.1x
Growth
Revenue growth8.1%5.8%9.9%
EPS growth16.7%9.3%33.7%
Profitability
Net margin37.2%24.1%17.2%
ROE66.4%31.7%22.3%
Balance sheet & cash
Debt / equity0.67x0.77x0.61x
Free cash flow yield37.3%4.2%3.1%
Dividend yield3.6%2.9%1.7%
Verdict
Investment ratingStrong· 76Favorable· 67Favorable· 68

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearNVOtoday $37NVStoday $141AZNtoday $157
2027$32.70 – $47.96+28% CAGR$115.45 – $169.32+20% CAGR$157.44 – $230.92+47% CAGR
2028$38.17 – $55.98+22% CAGR$126.15 – $185.02+15% CAGR$210.52 – $308.76+40% CAGR
2029$44.56 – $65.35+20% CAGR$137.84 – $202.17+13% CAGR$281.48 – $412.84+38% CAGR
2030$52.01 – $76.28+20% CAGR$150.62 – $220.91+12% CAGR$376.37 – $552.01+37% CAGR
2031$60.71 – $89.04+19% CAGR$164.58 – $241.39+11% CAGR$503.25 – $738.09+36% CAGR
5-yr CAGR10.2% – 19.0%3.2% – 11.4%26.2% – 36.3%